Use este identificador para citar ou linkar para este item:
http://www.repositorio.ufop.br/jspui/handle/123456789/10926
Título: | Comparing the therapeutic efficacy of different amphotericin Bcarrying delivery systems against visceral leishmaniasis. |
Autor(es): | Mendonça, Débora Vasconcelos Costa Martins, Vivian Tamietti Lage, Daniela Pagliara Ribeiro, Patrícia Aparecida Fernandes Carvalho, Ana Maria Ravena Severino Dias, Anna Leticia Teotonio Miyazaki, Carolina Kei Souza, Daniel Menezes Roatt, Bruno Mendes Tavares, Carlos Alberto Pereira Duarte, Mariana Costa Coelho, Eduardo Antônio Ferraz |
Palavras-chave: | Poloxamer 407 Treatment Toxicity |
Data do documento: | 2018 |
Referência: | MENDONÇA, D. V. C. et al. Comparing the therapeutic efficacy of different amphotericin Bcarrying delivery systems against visceral leishmaniasis. Experimental Parasitology, v. 186, p. 24-35, mar. 2018. Disponível em: <https://www.sciencedirect.com/science/article/pii/S0014489417303077?via%3Dihub>. Acesso em: 22 fev. 2019. |
Resumo: | Amphotericin B (Amp) has been well-successfully used to treat against Leishmania infection, although high toxicity has been found in patients. In the present study, Amp was administered in Leishmania infantum-infected BALB/c mice by three distinct delivery systems aiming to compare their efficacy against challenge infection, as well as their side effects in a murine visceral leishmaniasis (VL) model. This product was administered in a Poloxamer P407 (Pluronic® F127)-based polymeric micelle system (Amp/M), in the Ambisome® formulation (Lip-Amp) or in a free format (free Amp). Glucantime® (Gluc) was used as a comparative drug. Aiming to evaluate different endpoints of the treatments, the efficacy of the compounds was investigated one and 15-days after the therapeutic regimens, determining the parasite load by a limiting dilution assay and a quantitative PCR (qPCR) technique, as well as evaluating the immune response generated in the infected and treated animals. In the results, Amp/M or Lip-Amp-treated mice presented the best outcomes, since significant parasite load reductions were found in the evaluated organs, as well as a parasite-specific Th1 immune response was observed in the animals. In addition, no hepatic or renal damage was found in these mice. On the other hand, free Amp or Gluc induced toxicity in the animals, which was associated with a low Th1 immune response. Comparatively, Amp/M was the most effective drug in our experimental model, and results showed that the Amp-carrying system could be considered as a future alternative in studies against VL. |
URI: | http://www.repositorio.ufop.br/handle/123456789/10926 |
Link para o artigo: | https://www.sciencedirect.com/science/article/pii/S0014489417303077 |
ISSN: | 00144894 |
Aparece nas coleções: | DECBI - Artigos publicados em periódicos |
Arquivos associados a este item:
Arquivo | Descrição | Tamanho | Formato | |
---|---|---|---|---|
ARTIGO_ComparingTherapeuticEfficacy.pdf Restricted Access | 2,21 MB | Adobe PDF | Visualizar/Abrir |
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.